Cargando…

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture

A 24 year old woman with a chronic kidney disease of unknown etiology on hemodialysis with tertiary hyperparathyroidism, PTH of 3368 pg/ml (NV: 8-51 ) comes into the emergency room. She had fractures of both femurs after a fall in the bathroom. She underwent parathyroiddectomy leaving 50mg of the le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coy, Andres, Caceres, Katherin, Medina Orjuela, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552566/ http://dx.doi.org/10.1210/js.2019-SAT-509

Ejemplares similares

SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

SAT258 Successful Treatment Of Adult T-cell Leukemia-lymphoma Induced Hypercalcemia With Denosumab
por: Yuksel, Simge, et al.
Publicado: (2023)

SAT-512 Severe Hypocalcemia Presenting as Status Epilepticus after Denosumab Use in Metastatic Prostate Cancer
por: Saeed, Zeb, et al.
Publicado: (2019)

MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020)

SAT-365 Severe, Symptomatic Hypocalcemia Due to Denosumab and Vitamin D Deficiency in an Osteopenic Post-Menopausal Female
por: Berquist, John, et al.
Publicado: (2020)

SAT228 Denosumab Associated Severe Hypocalcemia Due To Vitamin D Deficiency In A Patient With Undiagnosed Primary Hyperparathyroidism
por: Reddy Bendaram, Snigdha, et al.
Publicado: (2023)

THU448 Multiple Non-traumatic Vertebral Fractures After Discontinuation Of Denosumab
por: Riahi, Shayan, et al.
Publicado: (2023)

Rebound-Associated Vertebral Fractures Two Months After a Missed Dose of Denosumab
por: Caseja, Ahl Jeffrey, et al.
Publicado: (2021)

FRI684 So Strong Yet So Fragile: Bilateral Periprosthetic Fractures On Denosumab
por: Syeda, Asma, et al.
Publicado: (2023)

MON-509 Crack in My Bone of Certain Significance: Clinical Vignette and Literature Review
por: Jalil, Fatima, et al.
Publicado: (2019)

MON-LB085 Blurred Vision and Hypocalcemia after Denosumab Injection in a Patient with Tertiary Hyperparathyroidism
por: Lim, Jayoung, et al.
Publicado: (2019)

SAT-403 Is Most “Primary” Hyperparathyroidism Both Tertiary and Preventable?
por: Innerfield, Ronald Jay
Publicado: (2020)

SAT-540 Bisphosphonates and Fracture Incidence in Young Adults
por: Choudhary, Manita, et al.
Publicado: (2019)

SUN-509 A Challenging Case of Symptomatic Primary Hyperparathyroidism during Pregnancy Treated with Cinacalcet
por: Rodriguez, Aleida, et al.
Publicado: (2019)

SAT-528 BMI and Relationship to Prior Fracture in the Super Obese
por: Iwamaye, Amy, et al.
Publicado: (2019)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

SAT-515 Racial-Ethnic Differences in Diabetes-Related Fracture Risk
por: Jain, Rajesh, et al.
Publicado: (2019)

MON-366 X Linked Hypophosphatemic Rachitism: Case Report in Adult Patient
por: Medina, Adriana, et al.
Publicado: (2020)

SAT-524 Re-hospitalization And Mortality Outcome Following Atypical Femur Fracture
por: Yang, Betsy, et al.
Publicado: (2019)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

SAT-389 Clinical and Biochemical Characterization of Risk Factors for Vertebral Fractures in Patients with Hypoparathyroidism
por: Formenti, Anna Maria, et al.
Publicado: (2020)

SAT232 Patients With Chronic Hypoparathyroidism Have Higher Risk Of Vertebral Fracture And Lower Risk Of Femoral Fracture Compared To Controls
por: Bjornsdottir, Sigridur, et al.
Publicado: (2023)

THU447 Hungry Bone Syndrome Secondary To Denosumab Use In A Patient With Sleeve Gastrectomy
por: Kumar, Arathi Prabha, et al.
Publicado: (2023)

SAT-522 Markers of Mineral Homeostasis and Bone Turnover in Patients Presenting with Acute Hip Fractures
por: Estrada, Kathleen, et al.
Publicado: (2019)

MON-517 Treatment of Gorham-Stout Disease with Combination Sirolimus and Denosumab
por: Hartley, Iris, et al.
Publicado: (2019)

SUN-513 Parathyromatosis: A Case of Stubborn Hypercalcemia Treated with Denosumab
por: Ventura, Kenilia, et al.
Publicado: (2019)

Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021)

SAT-398 The Use of Imaging in Primary Hyperparathyroidism
por: Broome, David Tyler, et al.
Publicado: (2020)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

Prolonged Hypocalcemia After a Single Dose of Denosumab in Chronic Kidney Disease
por: Puar, Akshan, et al.
Publicado: (2021)

PSAT197 Treatment of Paget's Disease of the Skull With Denosumab: A Case Report
por: Torfah, Maisoon, et al.
Publicado: (2022)

FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
por: Patil, Madhuri D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0qhs8rmj9d86ccg3pae5l6vbu1